The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel.
, alirocumab cuts deaths in post–acute coronary syndrome patients, the ODYSSEY Outcomes trial redefines secondary cardiovascular prevention, and how walking cuts postmenopausal women’s heart failure risk.
Listen to the MDedge Daily News podcast for all the details on today’s top news.